3BNC117-LS-J
Sponsors
International AIDS Vaccine Initiative, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Conditions
HIV-1-infection
Phase 1
Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults
CompletedNCT04173819
Start: 2019-01-25End: 2023-09-01Updated: 2025-05-06
Pausing Antiretroviral Treatment Under Structured Evaluation
CompletedNCT06031272
Start: 2024-05-28End: 2026-06-25Updated: 2026-08-17